Viewing Study NCT00425802


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2026-01-28 @ 8:49 PM
Study NCT ID: NCT00425802
Status: COMPLETED
Last Update Posted: 2017-10-31
First Post: 2007-01-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 06-150
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View